Virtual Incision Announces $46 Million Financing to Advance First-of-its-Kind MIRA Surgical Platform

IDE clinical study of robotic-assisted MIRA Surgical Platform currently underway for laparoscopic colon surgery

Lincoln, Neb., and Pleasanton, Calif. – November 30, 2021 – Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, today announced it has raised $46 million in a Series C funding round. The round was led by Endeavour Vision and Baird Capital with participation from returning investor Bluestem Capital and others. The funds will be used to support regulatory and clinical programs leading to the commercialization of the company’s MIRA® (“miniaturized in vivo robotic assistant”) Surgical Platform. Click here to view the press release.